V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20023196 | 20009845 | 1.71 | 69 | Adjuvant (A) | 2017-11-16 | 2017-11-20 | FEC + DOCETAXEL | 02 | N | 20081879 | FEC + DOCETAXEL |
| 20023197 | 20009846 | null | 54 | Adjuvant (A) | null | 2018-02-26 | FEC 100 + DOCETAXEL | null | null | 20081890 | FEC + DOCETAXEL |
| 20023198 | 20070647 | 1.61 | 69.9 | Adjuvant (A) | 2018-03-07 | 2018-03-08 | FEC 100 + DOCETAXEL | 2 | null | 20081892 | FEC + DOCETAXEL |
| 20023199 | 20070647 | 1.61 | 100 | Adjuvant (A) | null | 2014-07-16 | FEC + DOCETAXEL | N | N | 20081892 | FEC + DOCETAXEL |
| 20023200 | 20070647 | 1.66 | 87 | Adjuvant (A) | 2018-02-08 | 2018-02-08 | FEC + DOCETAXEL | 2 | null | 20081892 | FEC + DOCETAXEL |
| 20023201 | 20009847 | 1.69 | 49.6 | Adjuvant (A) | 2014-10-16 | 2014-10-23 | FEC + DOCETAXEL | 02 | N | 20081901 | FEC + DOCETAXEL |
| 20023202 | 20009848 | 1.67 | 80.9 | Adjuvant (A) | 2015-03-08 | 2015-03-13 | FEC 100 + DOCETAXEL | N | N | 20081902 | FEC + DOCETAXEL |
| 20023203 | 20009849 | 1.67 | 113.6 | Curative (C) | null | 2016-04-22 | FEC 100 + DOCETAXEL | N | N | 20081903 | FEC + DOCETAXEL |
| 20023204 | 20009849 | null | 59.4 | Adjuvant (A) | 2014-05-30 | 2014-06-14 | FEC + DOCETAXEL | N | N | 20081903 | FEC + DOCETAXEL |
| 20023205 | 20009850 | 1.65 | 74 | Adjuvant (A) | 2015-11-25 | 2015-11-26 | FEC + DOCETAXEL | 02 | N | 20081907 | FEC + DOCETAXEL |
| 20023206 | 20009851 | 1.56 | 61 | Curative (C) | 2016-01-15 | 2016-01-15 | FEC + DOCETAXEL | 02 | N | 20081908 | FEC + DOCETAXEL |
| 20023207 | 20009852 | 1.6 | 80.45 | Adjuvant (A) | 2016-09-05 | 2016-09-05 | FEC + DOCETAXEL | N | N | 20081910 | FEC + DOCETAXEL |
| 20023208 | 20009852 | 1.66 | 75.7 | Not known (9) | 2013-09-07 | 2013-09-13 | FEC + DOCETAXEL | 2 | N | 20081910 | FEC + DOCETAXEL |
| 20023209 | 20009852 | 1.58 | 66.3 | Adjuvant (A) | 2015-10-01 | 2015-10-19 | FEC 100 + DOCETAXEL | N | N | 20081910 | FEC + DOCETAXEL |
| 20023210 | 20009853 | null | 91 | null | 2014-08-02 | 2014-08-20 | FEC 100 + DOCETAXEL | N | null | 20081932 | FEC + DOCETAXEL |
| 20023211 | 20070650 | 1.65 | 63 | Adjuvant (A) | 2017-11-07 | 2017-11-17 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20081933 | FEC + DOCETAXEL |
| 20023212 | 20070650 | 1.56 | 70.3 | Adjuvant (A) | null | 2015-08-07 | FEC + DOCETAXEL | N | N | 20081933 | FEC + DOCETAXEL |
| 20023213 | 20009854 | 1.66 | 67.5 | Adjuvant (A) | 2018-06-19 | 2018-06-20 | FEC + DOCETAXEL | 2 | N | 20081941 | FEC + DOCETAXEL |
| 20023214 | 20070651 | null | null | Adjuvant (A) | 2015-11-19 | 2015-12-17 | FEC + DOCETAXEL | 2 | N | 20081949 | FEC + DOCETAXEL |
| 20023217 | 20009856 | 1.72 | 96.8 | Curative (C) | null | 2017-01-07 | FEC + DOCETAXEL | N | N | 20081963 | FEC + DOCETAXEL |
| 20023218 | 20009856 | 1.54 | 87.5 | Adjuvant (A) | null | 2018-04-09 | FEC 100 + DOCETAXEL | N | null | 20081963 | FEC + DOCETAXEL |
| 20023219 | 20009856 | 1.68 | 62.4 | Adjuvant (A) | 2013-10-08 | 2013-10-10 | FEC + DOCETAXEL | 02 | null | 20081963 | FEC + DOCETAXEL |
| 20023220 | 20009857 | 1.66 | 59 | Neo-adjuvant (N) | 2013-04-03 | 2013-04-05 | FEC + DOCETAXEL | 02 | N | 20081973 | FEC + DOCETAXEL |
| 20023221 | 20009857 | 1.71 | 63 | Adjuvant (A) | 2015-08-14 | 2015-09-13 | FEC + DOCETAXEL | N | N | 20081973 | FEC + DOCETAXEL |
| 20023222 | 20009858 | 1.75 | 98.8 | Adjuvant (A) | 2013-12-19 | 2013-12-19 | FEC + DOCETAXEL | 02 | N | 20081978 | FEC + DOCETAXEL |
| 20023223 | 20009858 | 1.62 | 59.5 | Adjuvant (A) | 2013-05-17 | 2013-07-09 | FEC 100 + DOCETAXEL | N | null | 20081978 | FEC + DOCETAXEL |
| 20023224 | 20009858 | 1.58 | 87.2 | Adjuvant (A) | 2013-09-18 | 2013-09-18 | FEC + DOCETAXEL | N | N | 20081978 | FEC + DOCETAXEL |
| 20023225 | 20009859 | 1.72 | 64 | Adjuvant (A) | 2016-12-06 | 2016-12-29 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20082009 | FEC + DOCETAXEL |
| 20023226 | 20009859 | 1.66 | 70 | Not known (9) | 2014-03-25 | 2014-03-25 | FEC + DOCETAXEL | 02 | N | 20082009 | FEC + DOCETAXEL |
| 20023227 | 20009860 | 1.62 | 52.2 | Adjuvant (A) | 2014-10-24 | 2014-10-24 | FEC 100 + DOCETAXEL | 02 | N | 20082016 | FEC + DOCETAXEL |
| 20023228 | 20009861 | 1.69 | 64 | Adjuvant (A) | 2015-01-05 | 2015-01-05 | FEC + DOCETAXEL | 02 | N | 20082018 | FEC + DOCETAXEL |
| 20023229 | 20009861 | 1.64 | 55 | Not known (9) | 2013-05-20 | 2013-05-21 | FEC 100 + DOCETAXEL | 02 | N | 20082018 | FEC + DOCETAXEL |
| 20023230 | 20009861 | 1.62 | 67.3 | Not known (9) | 2015-06-07 | 2015-06-17 | FEC + DOCETAXEL | N | N | 20082018 | FEC + DOCETAXEL |
| 20023231 | 20009861 | 1.73 | 72 | Adjuvant (A) | 2014-03-22 | 2014-03-27 | FEC + DOCETAXEL | N | N | 20082018 | FEC + DOCETAXEL |
| 20023232 | 20009862 | 1.61 | 60.4 | Adjuvant (A) | 2014-09-25 | 2014-10-08 | FEC 100 + DOCETAXEL | N | N | 20082029 | FEC + DOCETAXEL |
| 20023233 | 20009862 | 1.61 | 88.2 | Not known (9) | 2016-02-15 | 2016-03-07 | FEC 100 + DOCETAXEL | 02 | Y | 20082029 | FEC + DOCETAXEL |
| 20023234 | 20009862 | 1.61 | 76 | Neo-adjuvant (N) | 2013-06-21 | 2013-07-09 | FEC + DOCETAXEL | 02 | N | 20082029 | FEC + DOCETAXEL |
| 20023235 | 20009862 | 1.57 | 74 | Not known (9) | 2014-12-25 | 2015-01-06 | FEC 100 + DOCETAXEL | 02 | N | 20082029 | FEC + DOCETAXEL |
| 20023236 | 20009862 | 1.64 | 59 | Adjuvant (A) | null | 2017-07-15 | FEC 100 + DOCETAXEL | N | N | 20082029 | FEC + DOCETAXEL |
| 20023237 | 20009862 | 1.58 | 87.6 | Not known (9) | 2013-12-18 | 2013-12-19 | FEC + DOCETAXEL | 02 | null | 20082029 | FEC + DOCETAXEL |
| 20023238 | 20145838 | 1.71 | 52 | Adjuvant (A) | 2014-10-08 | 2014-10-08 | FEC 100 + DOCETAXEL | 02 | N | 20082054 | FEC + DOCETAXEL |
| 20023239 | 20009863 | 1.66 | 65.1 | Adjuvant (A) | 2015-11-16 | 2015-11-30 | FEC 100 + DOCETAXEL | N | null | 20082055 | FEC + DOCETAXEL |
| 20023240 | 20009864 | null | 70 | Adjuvant (A) | 2015-03-09 | 2015-03-20 | FEC + DOCETAXEL | 02 | N | 20082056 | FEC + DOCETAXEL |
| 20023241 | 20009865 | 1.68 | 78 | Adjuvant (A) | null | 2015-11-14 | FEC + DOCETAXEL | N | null | 20082060 | FEC + DOCETAXEL |
| 20023242 | 20009865 | 1.67 | 78.4 | Adjuvant (A) | 2013-10-07 | 2013-10-12 | FEC + DOCETAXEL | 02 | N | 20082060 | FEC + DOCETAXEL |
| 20023243 | 20009865 | 1.6 | 69.6 | Disease modification (D) | 2017-11-10 | 2017-11-14 | FEC + DOCETAXEL | 02 | N | 20082060 | FEC + DOCETAXEL |
| 20023244 | 20009866 | 1.54 | 79.9 | Adjuvant (A) | 2014-12-17 | 2015-01-08 | FEC + DOCETAXEL | Y | null | 20082076 | FEC + DOCETAXEL |
| 20023245 | 20009867 | 1.68 | 77.6 | Neo-adjuvant (N) | 2017-12-03 | 2017-12-17 | FEC + DOCETAXEL | N | N | 20082077 | FEC + DOCETAXEL |
| 20023246 | 20009867 | 1.63 | 66 | Adjuvant (A) | 2017-02-16 | 2017-02-16 | FEC + DOCETAXEL | 02 | N | 20082077 | FEC + DOCETAXEL |
| 20023247 | 20009868 | 1.66 | 62 | Adjuvant (A) | 2017-10-06 | 2017-10-07 | FEC + DOCETAXEL | 02 | N | 20082080 | FEC + DOCETAXEL |